US Patent Issued to New England Biolabs on May 27 for "Vaccinia capping enzyme compositions and methods" (Massachusetts Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,610, issued on May 27, was assigned to New England Biolabs Inc. (Ipswich, Mass.).

"Vaccinia capping enzyme compositions and methods" was invented by Saulius Vainauskas (Newburyport, Mass.), Siu-hong Chan (Ipswich, Mass.) and Christopher H. Taron (Essex, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates, according to some embodiments, to compositions, methods, and/or kits for producing vaccinia capping enzyme. For example, active, heterodimers of vaccinia capping enzyme may be produced as fusions comprising D1 and D12 subunits. Vaccinia capping enzyme fusion proteins may further comprise a linker."

The patent was fi...